| The Regents of the University of California | 565 | 58% |
| BASF SE | 368 | 35% |
| The Procter & Gamble Company | 318 | 25% |
| L'Oréal | 284 | 79% |
| Board of Regents of the University of Texas System | 269 | 64% |
| The Board of Trustees of the Leland Stanford Junior University | 191 | 62% |
| The Johns Hopkins University | 183 | 64% |
| Nestlé S.A. | 177 | 28% |
| Massachusetts Institute of Technology | 176 | 55% |
| The Regents of the University of Michigan | 149 | 39% |
| Sanofi S.A. | 147 | 28% |
| Regeneron Pharmaceuticals Inc. | 145 | 84% |
| Purdue Research Foundation | 141 | 43% |
| THE GENERAL HOSPITAL Corporation | 138 | 63% |
| Henkel AG & Co. KGaA | 133 | 28% |
| Amgen Inc. | 129 | 66% |
| The Trustees of the University of Pennsylvania | 125 | 75% |
| Illumina Inc. | 124 | 73% |
| Syngenta AG | 117 | 97% |
| Northwestern University | 117 | 55% |
| University of Florida Research Foundation Inc. | 115 | 70% |
| Wisconsin Alumni Research Foundation | 115 | 65% |
| President and Fellows of Harvard College | 115 | 74% |
| Seoul National University R&DB Foundation | 114 | 26% |
| Arizona Board of Regents on Behalf of Arizona State University | 112 | 39% |
| Mayo Foundation for Medical Education and Research | 108 | 42% |
| Hoffmann-La Roche Inc. | 106 | 81% |
| 10x Genomics Inc. | 101 | 76% |
| The Trustees of Columbia University in the City of New York | 95 | 57% |
| Genentech Inc. | 93 | 74% |
| Conopco, Inc. d/b/a Unilever | 92 | 53% |
| Merck Patent GmbH | 91 | 39% |
| California Institute of Technology | 91 | 43% |
| University of Pittsburgh | 91 | 60% |
| DSM IP Assets B.V. | 90 | 62% |
| Novartis AG | 86 | 98% |
| Columbia University | 86 | 65% |
| The Ohio State University | 85 | 49% |
| Duke University | 85 | 75% |
| Korea University Research and Business Foundation | 84 | 33% |
| CJ CheilJedang Corporation | 83 | 47% |
| Regents of the University of Minnesota | 83 | 41% |
| Colgate-Palmolive Company | 81 | 69% |
| Washington University | 80 | 59% |
| Kao Corporation | 78 | 67% |
| GEORGIA TECH RESEARCH Corporation | 77 | 22% |
| Evonik Operations GmbH | 76 | 41% |
| The Regents of the University of Colorado | 74 | 49% |
| University of Washington | 72 | 70% |
| Arizona Board of Regents on Behalf of the University of Arizona | 71 | 56% |
| Sekisui Chemical Co., Ltd. | 70 | 25% |
| Thermo Fisher Scientific | 70 | 56% |
| Novozymes A/S | 70 | 72% |
| Janssen Pharmaceuticals Inc. | 69 | 85% |
| Denka Company Limited | 69 | 21% |
| University of Massachusetts | 68 | 71% |
| Kaneka Corporation | 68 | 25% |
| Yale University | 67 | 75% |
| Merck Sharp & Dohme LLC | 66 | 78% |
| Boehringer Ingelheim International GmbH | 65 | 88% |
| University of Virginia Patent Foundation | 65 | 62% |
| Vanderbilt University | 64 | 51% |
| Cargill Incorporated | 64 | 25% |
| Korea Institute of Science and Technology | 62 | 25% |
| Tohoku University | 61 | 51% |
| Zhejiang University | 61 | 39% |
| Daicel Corporation | 61 | 34% |
| Centre National de la Recherche Scientifique | 60 | 36% |
| The Texas A&M University System | 59 | 43% |
| SUMITOMO CHEMICAL Company, Limited | 59 | 41% |
| United States Department of Veterans Affairs | 58 | 71% |
| Nanyang Technological University | 57 | 35% |
| The Board of Trustees of the University of Illinois | 57 | 51% |
| Takeda Pharmaceutical Company Limited | 57 | 95% |
| Pioneer Hi-bred International Inc. | 56 | 95% |
| The University of Tokyo | 54 | 48% |
| Givaudan S.A. | 54 | 54% |
| Bristol-Myers Squibb Company | 53 | 82% |
| The University of North Carolina at Chapel Hill | 53 | 79% |
| Case Western Reserve University | 53 | 41% |
| The Research Foundation for the State University of New York | 53 | 37% |
| Eli Lilly and Company | 52 | 69% |
| University of South Florida | 52 | 35% |
| Osaka University | 52 | 54% |
| University of Southern California | 51 | 50% |
| Rutgers, The State University of New Jersey | 51 | 62% |
| Pfizer Inc. | 51 | 84% |
| Firmenich S.A. | 51 | 36% |
| The Brigham and Women's Hospital Inc. | 50 | 70% |
| Dana-Farber Cancer Institute Inc. | 50 | 100% |
| Flagship Pioneering Inc. | 50 | 96% |
| Monsanto Technology LLC | 50 | 80% |
| Bayer Aktiengesellschaft | 49 | 67% |
| University of Utah Research Foundation | 49 | 53% |
| North Carolina State University | 49 | 49% |
| Ajinomoto Co., Inc. | 49 | 47% |
| Roche Diagnostics Operations Inc. | 48 | 48% |
| The Penn State Research Foundation | 48 | 43% |
| SHISEIDO Company, Ltd. | 48 | 85% |
| H. Lee Moffitt Cancer Center and Research Institute Inc. | 48 | 92% |
| City of Hope | 48 | 92% |
| VERADERMICS INCORPORATED | 47 | 91% |
| The Trustees of Princeton University | 46 | 46% |
| Otsuka Pharmaceutical Co., Ltd. | 46 | 74% |
| Nissan Chemical Corporation | 45 | 23% |
| National University of Singapore | 45 | 38% |
| The University of Chicago | 45 | 73% |
| City University of Hong Kong | 44 | 23% |
| Symrise AG | 44 | 63% |
| Astrazeneca AB | 43 | 90% |
| Oxford University Innovation Limited | 43 | 53% |
| Memorial Sloan Kettering Cancer Center | 43 | 93% |
| National Tsing Hua University | 42 | 19% |
| National Institute of Advanced Industrial Science and Technology | 41 | 22% |
| Chugai Seiyaku Kabushiki Kaisha | 41 | 93% |
| Covestro AG | 41 | 24% |
| University of Cincinnati | 41 | 42% |
| Ramot At Tel-aviv University Ltd. | 41 | 66% |
| Agency for Science, Technology and Research | 41 | 54% |
| The University of Hong Kong | 40 | 65% |
| Ucl Business Ltd. | 39 | 74% |
| Alnylam Pharmaceuticals Inc. | 39 | 100% |
| Gilead Sciences Inc. | 38 | 95% |
| University of South Carolina | 38 | 37% |
| King Abdullah University of Science and Technology | 38 | 21% |
| Ut-battelle LLC | 38 | 22% |
| University of Maryland, College Park | 38 | 29% |
| New York University | 37 | 42% |
| United States Department of Health and Human Services | 37 | 91% |
| Ajou University Industry-Academic Cooperation Foundation | 36 | 43% |
| Kyoto University | 36 | 53% |
| Agilent Technologies Inc. | 35 | 29% |
| Northeastern University | 35 | 23% |
| Rohm And Haas Company | 35 | 32% |
| Emory University | 35 | 66% |
| INCYTE Corporation | 35 | 100% |
| Janssen Pharmaceutica NV | 35 | 86% |
| Inari Agriculture Technology Inc. | 34 | 100% |
| Virginia Polytechnic Institute and State University | 34 | 29% |
| Icahn School of Medicine At Mount Sinai | 34 | 76% |
| Yeda Research and Development Co. Ltd. | 34 | 79% |
| ModernaTX Inc. | 33 | 100% |
| Riken | 33 | 47% |
| Trustees of Tufts College | 33 | 64% |
| Industry-academic Cooperation Foundation, Yonsei University | 33 | 55% |
| The Curators of the University of Missouri | 33 | 56% |
| The Trustees of Dartmouth College | 33 | 62% |
| Cambridge Enterprise Limited | 33 | 58% |
| Imperial College Innovations Limited | 33 | 70% |
| University of Kentucky Research Foundation | 33 | 52% |
| AbbVie Inc. | 32 | 78% |
| Wacker Chemie AG | 32 | 34% |
| Nippon Shokubai Co., Ltd. | 31 | 23% |
| The Chinese University of Hong Kong | 31 | 71% |
| National University Corporation Tokai National Higher Education and Research System | 31 | 35% |
| Technion Research & Development Foundation Limited | 31 | 52% |
| University of Connecticut | 31 | 65% |
| Baylor College of Medicine | 31 | 87% |
| Cedars-Sinai Medical Center | 30 | 82% |
| University Health Network | 30 | 67% |
| Amano Enzyme Inc. | 30 | 27% |
| Qatar Foundation for Education, Science and Community Development | 30 | 25% |
| Grail LLC | 30 | 100% |
| Singular Genomics Systems Inc. | 29 | 90% |
| Katholieke Universiteit Leuven | 29 | 31% |
| SYSMEX Corporation | 29 | 32% |
| The Governing Council of the University of Toronto | 29 | 39% |
| Vertex Pharmaceuticals Incorporated | 29 | 100% |
| Research Institute At Nationwide Children's Hospital | 29 | 97% |
| Novo Nordisk A/S | 28 | 71% |
| The Cleveland Clinic Foundation | 28 | 54% |
| The Trustees of Indiana University | 28 | 68% |
| Drexel University | 28 | 28% |
| Max-planck-gesellschaft Zur Förderung der Wissenschaften E.v. | 28 | 58% |
| Chr. Hansen A/S | 28 | 52% |
| Mcmaster University | 28 | 64% |
| Danisco US Inc. | 28 | 93% |
| IFP Energies nouvelles | 27 | 27% |
| Iowa State University Research Foundation Inc. | 27 | 33% |
| The Hong Kong University of Science and Technology | 27 | 28% |
| Tosoh Corporation | 27 | 20% |
| Idexx Laboratories Inc. | 27 | 31% |
| The Children's Medical Center Corporation | 27 | 81% |
| GENZYME Corporation | 26 | 88% |
| Bio-Rad Laboratories Inc. | 26 | 65% |
| Brown University | 26 | 50% |
| University of Houston System | 26 | 54% |
| Keio University | 26 | 54% |
| Children's Medical Center Corporation | 26 | 77% |
| National Research Council of Canada | 26 | 31% |
| École Polytechnique Fédérale de Lausanne | 26 | 32% |
| Glaxosmithkline Biologicals S.A. | 26 | 96% |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 26 | 100% |
| Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | 26 | 77% |
| The University of British Columbia | 25 | 72% |
| Bayer HealthCare LLC | 25 | 40% |
| West Virginia University | 25 | 25% |
| Tempus AI Inc. | 25 | 44% |
| Roche Sequencing Solutions Inc. | 25 | 71% |
| William Marsh Rice University | 25 | 44% |
| Intervet Inc. | 25 | 96% |
| AMOREPACIFIC Corporation | 25 | 80% |
| ELC Management LLC | 25 | 28% |
| University of Maryland, Baltimore | 25 | 76% |
| Eidgenössische Technische Hochschule Zürich | 25 | 33% |
| Speciality Operations France | 25 | 65% |
| Gwangju Institute of Science and Technology | 25 | 28% |
| The Board of Regents of the University of Oklahoma | 25 | 44% |
| Fred Hutchinson Cancer Research Center | 25 | 100% |
| University of Louisville Research Foundation Inc. | 25 | 58% |
| L’Oréal | 4 | 75% |
| Mayo Foundation for Medical Education and Research | 2 | 100% |
